We Work For Health

What We Work For Health does

We Work For Health (WWFH) is a U.S.-based nonprofit policy advocacy coalition that operates as a multi-stakeholder intermediary for the American life sciences sector. Its stated mission is to bring together national and local business leaders, labor organizations, biopharmaceutical companies, patient advocacy groups, educators, and other healthcare-related constituencies to support policies and initiatives that foster innovation and the delivery of lifesaving and life-enhancing medicines. WWFH does not develop or sell commercial technology products; instead, its core outputs are advocacy infrastructure — research and data products, policy frameworks, multi-channel communications, and direct engagement with federal and state policymakers — deployed to influence legislation and rulemaking in areas such as drug pricing (opposition to Most Favored Nation and IRA provisions), intellectual property protections (support for the EPIC Act), workforce policy, and manufacturing incentives. Its documented core 'products' are a Policy Framework document outlining advocacy positions, a Resources Hub aggregating economic-impact, patent, biosimilar, and price-control research, and a U.S. Biopharma Investment Watch tracking tool that has documented over $582 billion in announced U.S. biopharma facility investments since January 2025.

WWFH is headquartered in Wilmington, DE, with a privacy-policy jurisdiction in the District of Columbia and an operational footprint across all 50 states, DC, and Puerto Rico. It employs 51-100 staff and is led by Executive Director Dan Leonard. The organization is funded and governed without a disclosed parent entity, private equity backing, or institutional investment structure; no funding rounds, ownership changes, or M&A activity were disclosed in the source material. Marketing and distribution channels are configured for advocacy reach rather than commercial sales: a website (weworkforhealth.org), a podcast (Vital Health), a YouTube series, op-eds and press releases, and roundtables co-hosted with partners such as the Council for Innovation Promotion (C4IP), Life Sciences Pennsylvania (LSPA), the Pharmaceutical Industry Labor-Management Association (PILMA), the HealthCare Institute of New Jersey (HINJ), the North Carolina Life Sciences Organization, the Montana BioScience Alliance, and the Tennessee Men's Health Network. Because WWFH is a nonprofit coalition rather than a revenue-generating enterprise, pricing models, customer counts, and revenue figures are not applicable and not disclosed. The 'revenue model' is implicit: programmatic and operational funding from coalition members and stakeholders to sustain advocacy activities.

Strategic differentiation rests on three pillars: (1) the breadth of the coalition — uniting otherwise adversarial stakeholders such as industry and labor under a single U.S.-life-sciences competitiveness umbrella; (2) the specificity of its data products, including the Investment Watch tracker and state-level economic impact datasets that quantify 4.9 million supported U.S. jobs and $71.6B+ in annual vendor spending; and (3) sustained presence in the federal and state policy debate around drug pricing, IP, and manufacturing incentives, with explicit expansion into a Global Competition framing against Europe and China.

Name

We Work For Health

Legal name

We Work For Health

Website

https://weworkforhealth.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

We Work For Health is a U.S. nonprofit policy advocacy coalition uniting business, labor, biopharmaceutical companies, patient advocates, and educators to influence federal and state life sciences policy on drug pricing, intellectual property, and innovation.

Ownership category

akta.pro rank

Product category

Healthcare Policy Advocacy

NAICS

Voluntary Health Organizations (813212), Administration of Public Health Programs (923120)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industries

Healthcare & Life Sciences PR (MPAAADAD), Patient Advocacy, Navigation & Access to Care (BPAGACAH)

Keywords

• Healthcare policy advocacy
• Biopharmaceutical research
• Life sciences policy
• Patient advocacy coalition
• Nonprofit health advocacy

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Distribution channels2 records

Marketing channels7 records

Core offering

We Work For Health is a non-profit advocacy coalition that convenes business leaders, labor, biopharmaceutical companies, patient advocates, and other stakeholders to support U.S. life sciences innovation policy. It provides policy research, advocacy resources, and stakeholder coordination aimed at influencing legislation and regulation affecting the biopharmaceutical sector in the United States.

Product overview

We Work For Health is an advocacy organization (not a software product company) that provides informational resources, policy advocacy tools, and data tracking services. Its core offerings include the U.S. Biopharma Investment Watch tracking tool, a Resources Hub covering jobs, intellectual property, and pricing policy research, and a Policy Framework document outlining its advocacy positions on life sciences innovation.

Differentiator

Problem solved

Functional benefit

Products and services

• U.S. Biopharma Investment Watch Research and data product tracking U.S. biopharmaceutical investment trends, provided to policymakers, coalition members, and stakeholders to support evidence-based life sciences policy advocacy.
• Resources Hub Online hub of educational and advocacy resources on U.S. life sciences innovation policy, intended for coalition members, stakeholders, and the public seeking information on biopharmaceutical policy issues.
• Policy Framework Structured advocacy blueprint outlining the coalition's policy positions and recommendations to support U.S. biopharmaceutical innovation, used to engage policymakers and legislators.

Quantifiable outcome

• 4.9 million total U.S. jobs supported by life sciences sector
• +3 more outcomes

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Council for Innovation Promotion (C4IP)coreStrategic or Co-development PartnerCo-hosted roundtable events with C4IP focusing on intellectual property protections in life sciences. Partnered for 'Securing U.S. Innovation: The Role of IP in Advancing Life Sciences' event in North Carolina featuring Congresswoman Deborah Ross.
• Life Sciences Pennsylvania (LSPA)coreStrategic or Co-development PartnerPartnership for Pennsylvania Innovation Roundtable at Rockland Immunochemicals near Philadelphia, convening life sciences sector leaders with Rep. Madeleine Dean to discuss innovation policy.
• Pharmaceutical Industry Labor-Management Association (PILMA)coreStrategic or Co-development PartnerWWFH references PILMA research on how pharmaceutical and biotech companies contribute to U.S. economy through infrastructure investment and job creation, including studies on union labor in construction.
• HealthCare Institute of New Jersey (HINJ)minorStrategic or Co-development PartnerBoth organizations work on life sciences sector advocacy in New Jersey. HINJ President Chrissy Buteas co-authored op-ed with WWFH on MFN drug pricing impact on New Jersey.
• North Carolina Life Sciences Organization (NCLifeSci)minorStrategic or Co-development PartnerEndorsed EPIC Act legislation and advocates for small-molecule drug innovation. Laura Gunter, President, provided statement supporting WWFH's policy positions.
• Montana BioScience AllianceminorStrategic or Co-development PartnerAdvocacy partner supporting EPIC Act legislation. Cassandra Sunell provided statement endorsing policy positions.
• Tennessee Men's Health NetworkminorStrategic or Co-development PartnerPartner advocating for small-molecule drug innovation. Executive Director Mike Leventhal endorsed EPIC Act.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Council for Innovation Promotion (C4IP): An advocacy coalition focused on intellectual property protections, with whom WWFH co-hosts policy roundtables. Highly comparable in coalition-driven advocacy model and policy positioning on IP.
• Biotechnology Innovation Organization (BIO): The primary U.S. biotechnology industry advocacy organization, lobbying on IP, drug pricing, and innovation policy. Directly comparable to WWFH in mission and stakeholder base, with a stronger biotech-company focus.
• PhRMA (Pharmaceutical Research and Manufacturers of America): The largest U.S. biopharmaceutical industry trade association, conducting policy advocacy, communications, and data products in the same life sciences policy space as WWFH. It is the most direct and well-funded peer in biopharma advocacy.
• Pharmaceutical Industry Labor-Management Association (PILMA): A labor-management coalition whose research on biopharma construction jobs and infrastructure investment WWFH references and partners with. Comparable in bringing labor and industry together around life sciences advocacy.

Regional players

• Healthcare Institute of New Jersey (HINJ): A New Jersey life sciences industry advocacy group that has co-authored op-eds with WWFH on MFN drug pricing. Directly comparable as a regional/state-level life sciences advocacy organization.
• Life Sciences Pennsylvania (LSPA): A Pennsylvania life sciences trade association with which WWFH has partnered for state-level innovation roundtables. Comparable in mission and state-level advocacy approach.
• North Carolina Life Sciences Organization (NCLifeSci): A state-level life sciences advocacy group in North Carolina that has publicly endorsed WWFH's policy positions on the EPIC Act. Comparable in mission and regional advocacy model.

Emerging players

• National Patient Advocate Foundation: A patient advocacy organization focused on access to affordable care and medicines. Comparable to WWFH's patient advocacy stakeholder base but with a narrower, patient-centered focus.
• Global Health Technologies Coalition: An advocacy coalition promoting R&D for global health technologies. Comparable to WWFH in coalition-driven R&D advocacy but with a global health and product-development focus rather than U.S. policy.

Broad incumbents

• AdvaMed (Advanced Medical Technology Association): The largest U.S. medical device and diagnostics industry advocacy organization. A broader incumbent that overlaps with WWFH on innovation policy, IP, and payment reform but focuses on medical technology rather than biopharmaceuticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/we-work-for-health-delaware
• YouTubeyoutube.com/channel/UCp7yF36C1X4Xgd5qdZcuBvw
• Xx.com/weworkforhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about We Work For Health